Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Alemtuzumab (Lemtrada) - NICE says yes in final draft guidance
Identification of protein networks involved in the disease course of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
Rectus abdominis muscle endometriotic mass in a woman affected by multiple sclerosis.
The role of laquinimod in modulation of the immune response in relapsing-remitting multiple sclerosis: Lessons from gene expression signatures.
Cytokines and Disability in Interferon-β-1b Treated and Untreated Women with Multiple Sclerosis.
Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment.
Raltegravir (Isentress) pilot study in relapsing multiple sclerosis (INSPIRE)
Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.
Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia.
Acute disseminated encephalomyelitis--a prospective study of clinical profile and in-hospital outcome predictors.
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.
Central Nervous System Herpes Simplex and Varicella-Zoster Virus Infections in Natalizumab-Treated Patients.
Long-Term Results Underscore Value of Early MS Treatment
Response to "Glucocorticoids for treating Takotsubo syndrome?" and "Atypical global Takotsubo syndrome in a patient with acute disseminated encephalomyelitis".
Design and screening of a glial cell-specific, cell penetrating Peptide for therapeutic applications in multiple sclerosis.
Solodyn
PEGylated interferon beta-1a in the treatment of multiple sclerosis - an update.
Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions.
An Adult Case of Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Multiphasic Acute Disseminated Encephalomyelitis at 33-year Intervals.
Multiple sclerosis treatment: current best practice.
In vivo evidence of glutamate toxicity in multiple sclerosis.
Cytokine profile in relapsing‑remitting multiple sclerosis patients and the association between progression and activity of the disease.
Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases.

Pages